Literature DB >> 16287165

Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug.

Ying Wang1, Qing-Yu He, Chi-Ming Che, Jen-Fu Chiu.   

Abstract

There has been increasing interest in the potential applications of gold (III) complexes as anticancer drugs with higher cytotoxicity and fewer side effects than existing metal anticancer drugs. Our previous findings demonstrated that gold (III) porphyrin 1a preferentially induced apoptosis in a cancer cell line (SUNE1). In this study, we identified differentially expressed proteins related to the drug's cytotoxic action by comparing the protein alterations induced by gold (III) porphyrin 1a and cisplatin treatments. Several clusters of altered proteins were identified, including cellular structure and stress-related chaperone proteins, proteins involved in reactive oxygen species and enzyme proteins, translation factors, proteins that mediate cell proliferation or differentiation, and proteins participating in the internal degradation systems. Our results indicated that multiple factors leading to apoptosis were involved in drug cytotoxicity in SUNE1 cells. The balance between pro-apoptotic and anti-apoptotic signals determined the final fate of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16287165     DOI: 10.1002/pmic.200402027

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  11 in total

1.  Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study.

Authors:  Francesca Magherini; Alessandra Modesti; Luca Bini; Michele Puglia; Ida Landini; Stefania Nobili; Enrico Mini; Maria Agostina Cinellu; Chiara Gabbiani; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2010-01-29       Impact factor: 3.358

2.  [Zn(phen)(O,N,O)(H2O)] and [Zn(phen)(O,N)(H2O)] with O,N,O is 2,6-dipicolinate and N,O is L-threoninate: synthesis, characterization, and biomedical properties.

Authors:  Lee-Fang Chin; Siew-Ming Kong; Hoi-Ling Seng; Yee-Lian Tiong; Kian-Eang Neo; Mohd Jamil Maah; Alan Soo-Beng Khoo; Munirah Ahmad; Tzi-Sum Andy Hor; Hong-Boon Lee; Swee-Lan San; Soi-Moi Chye; Chew-Hee Ng
Journal:  J Biol Inorg Chem       Date:  2012-07-24       Impact factor: 3.358

3.  A porphyrin complex of gold(I): (phosphine)gold(I) azides as cation precursors.

Authors:  David V Partyka; Thomas J Robilotto; Matthias Zeller; Allen D Hunter; Thomas G Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

4.  DNA interactions and photocatalytic strand cleavage by artificial nucleases based on water-soluble gold(III) porphyrins.

Authors:  Martin Haeubl; Lorenz Michael Reith; Bernadette Gruber; Uwe Karner; Norbert Müller; Günther Knör; Wolfgang Schoefberger
Journal:  J Biol Inorg Chem       Date:  2009-05-27       Impact factor: 3.358

5.  The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy.

Authors:  Vesna Milacic; Q Ping Dou
Journal:  Coord Chem Rev       Date:  2009       Impact factor: 22.315

6.  Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.

Authors:  Ying Wang; Jen-Fu Chiu
Journal:  Met Based Drugs       Date:  2008

7.  An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells.

Authors:  Samuel M Meier-Menches; Benjamin Neuditschko; Katja Zappe; Martin Schaier; Marlene C Gerner; Klaus G Schmetterer; Giorgia Del Favero; Riccardo Bonsignore; Margit Cichna-Markl; Gunda Koellensperger; Angela Casini; Christopher Gerner
Journal:  Chemistry       Date:  2020-11-03       Impact factor: 5.236

8.  Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition.

Authors:  W Li; Y Xie; R W-Y Sun; Q Liu; J Young; W-Y Yu; C-M Che; P K Tam; Y Ren
Journal:  Br J Cancer       Date:  2009-06-23       Impact factor: 7.640

Review 9.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

Review 10.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.